You are here:

erdosteine 300mg capsules (Erdotin)


Following a full submission

erdosteine (Erdotin®) is not recommended for use within NHS Scotland as an expectorant for the symptomatic treatment of acute exacerbations of chronic bronchitis in adults.

Evidence for the clinical efficacy of erdosteine is limited and was obtained from studies that do not reflect current practice for the management of chronic obstructive pulmonary disease (COPD) in NHS Scotland. The manufacturer did not present a sufficiently robust clinical or economic case for erdosteine to gain acceptance by SMC.

Drug Details

Drug Name: erdosteine 300mg capsules (Erdotin)
SMC Drug ID: 415/07
Manufacturer: Edmond Pharma Sr.I/Galen Ltd
Indication: Chronic Bronchitis in adults
BNF Category:
Sub Category: 3.7 Mucolytics
Submission Type: Full submission
Status: Not Recommended
Date Advice Published: 12 November 2007